Related Experiment Video
Updated: Apr 2, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Hemoglobin thresholds for transfusion in pediatric patients at a large academic health center
Sybil A Klaus1, Steven M Frank2, Jose H Salazar3
1Department of Pediatrics, the Johns Hopkins Medical Institutions, Baltimore, Maryland.
Insights
Pediatric red blood cell (RBC) transfusions often exceed recommended hemoglobin (Hb) triggers. Implementing restrictive transfusion strategies in children could reduce RBC use and associated risks.
Area of Science:
- Pediatric Hematology
- Transfusion Medicine
- Hospital Quality Improvement
Background:
- Existing evidence supports hemoglobin (Hb) transfusion triggers of 7–8 g/dL for adults.
- Limited research exists on transfusion practices in pediatric populations.
Purpose of the Study:
- To investigate red blood cell (RBC) transfusion practices and hemoglobin (Hb) triggers in hospitalized children.
- To compare current pediatric transfusion practices against evidence-based restrictive thresholds.
Main Methods:
- A historical cohort study was conducted at a single academic institution.
- Blood utilization data from 3,370 transfused pediatric patients were analyzed over four years.
- Hemoglobin (Hb) triggers and posttransfusion Hb levels were determined and compared to a 7 g/dL restrictive threshold.
Main Results:
- Mean Hb triggers exceeded the 7 g/dL threshold in eight of 12 pediatric services.
- Significant variations in mean Hb triggers (>2.5 g/dL) and posttransfusion Hb levels (>3 g/dL) were observed across services (p<0.0001).
- Between 25% and 90% of transfused pediatric patients had Hb triggers above the restrictive range, depending on the service.
Conclusions:
- Red blood cell (RBC) transfusion practices vary significantly among hospitalized children.
- Mean Hb triggers are frequently above restrictive thresholds, suggesting potential overuse of RBC transfusions.
- Adopting a restrictive transfusion strategy could decrease RBC utilization, mitigating associated risks and costs.
Background:
Although prior studies support the use of a hemoglobin (Hb) transfusion trigger of 7 to 8 g/dL for most hospitalized adults, there are few studies in pediatric populations. We therefore investigated transfusion practices and Hb triggers in hospitalized children.
Study Design And Methods:
We performed a historical cohort study comparing transfusion practices in hospitalized children by service within a single academic institution. Blood utilization data from transfused patients (n = 3370) were obtained from electronic records over 4 years. Hb triggers and posttransfusion Hb levels were defined as the lowest and last Hb measured during hospital stay, respectively, in transfused patients. The mean and percentile distribution for Hb triggers were compared to the evidence-based restrictive transfusion threshold of 7 g/dL.
Results:
Mean Hb triggers were above the restrictive trigger (7 g/dL) for eight of 12 pediatric services. Among all of the services, there were significant differences between the mean Hb triggers (>2.5 g/dL, p<0.0001) and between the posttransfusion Hb levels (>3 g/dL, p < 0.0001). The variation between the 10th and 90th percentiles for triggers (up to 4 g/dL, p < 0.0001) and posttransfusion Hb levels (up to 6 g/dL, p < 0.0001) were significant. Depending on the service, between 25 and 90% of transfused patients had Hb triggers higher than the restrictive range.
Conclusions:
Red blood cell (RBC) transfusion therapy varies significantly in hospitalized children with mean Hb triggers above a restrictive threshold for most services. Our findings suggest that transfusions may be overused and that implementing a restrictive transfusion strategy could decrease the use of RBC transfusions, thereby reducing the associated risks and costs.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Oxygen Transport in the Blood
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion